Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Camden National Corporation SEC filings document formal disclosures for a publicly traded bank holding company and its community banking operations. Material-event reports furnish quarterly and annual earnings releases, dividend declarations, share repurchase authorization, and investor presentation materials.
The company’s proxy filings cover governance and executive-compensation matters, including equity awards and pension-related compensation measures. Together, the filings record Camden National’s reported operating results, capital-return actions, common-stock matters, board oversight, and public-company reporting obligations.
CAMDEN NATIONAL CORP director Larry K. Haynes reported routine equity and ownership updates. On June 1, 2026, he acquired 919 shares of Common Stock at no cost as a stock grant under the Independent Directors' Equity Compensation Program, which vested immediately.
On May 11, 2026, 3,217.888 shares of Common Stock were moved from his direct holdings into a revocable trust, where he serves as trustee and retains voting and dispositive power, so there was no change in his beneficial ownership. Footnotes also note 33.057 additional shares accumulated since the last filing through the company’s dividend reinvestment program.
Merrill Robert D reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Robert D. Merrill received a stock grant of 919 shares of Common Stock as compensation. The shares were granted under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.
The grant carried no purchase price and vested immediately on the grant date, meaning Merrill gained full ownership right away. Following this award, his direct holdings increased to 11,423.8065 shares of Camden National Corp common stock, reflecting a routine, compensation-related equity increase rather than an open-market purchase.
Longley S. Catherine reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Catherine S. Longley received an equity award of 919 shares of Common Stock under the company’s Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment. The grant carried no purchase price and vested immediately on the grant date.
Following this award, Longley directly holds a total of 14,512.613 shares of Camden National Corp common stock. This filing reflects routine director compensation rather than an open-market stock purchase or sale.
Page James H reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director James H. Page received a grant of 919 shares of Common Stock as equity compensation. The shares were awarded under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date. After this award, Page directly holds 10,896 shares of Camden National Corp common stock.
Denekas Craig N reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Craig N. Denekas received a grant of 919 shares of common stock. The shares were awarded on June 1, 2026 under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and Amendment.
The award was an equity compensation grant with no cash price per share and vested immediately on the grant date. Following this grant, Denekas directly holds 15,999 shares of Camden National common stock, reflecting his updated ownership position as a director.
Hatfield Rebecca reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Rebecca Hatfield received a grant of 919 shares of common stock under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment. The award carried no purchase price and vested immediately on the grant date.
Following this compensation grant, Hatfield directly holds a total of 8,461.445 shares of Camden National common stock. A footnote also notes an additional 0.422 share accumulated since the prior filing through participation in the company’s dividend reinvestment program.
Camden National Corporation reported results of its 2026 Annual Meeting of Shareholders held in a virtual-only format. Shareholders representing 14,153,902 common shares, about 83% of eligible votes, were present virtually or by proxy.
All eleven director nominees received majority support and were elected to one-year terms. Shareholders also approved, on a non-binding basis, the compensation of the company’s named executive officers. In addition, they ratified the appointment of RSM US LLP as independent registered public accounting firm for the year ending December 31, 2026.
Camden National Corp EVP Garrett McKnight had 45 shares of Common Stock withheld on May 15, 2026 to cover minimum tax obligations on restricted stock units that vested that day. The shares were valued at $47.34 per share and this was not an open-market sale.
After this tax-withholding disposition, McKnight directly holds 6,223 shares of Camden National stock, including 4,248 restricted stock units and restricted shares that remain subject to future vesting and forfeiture conditions.
Camden National Corporation announced that William H. Martel, its Executive Vice President and Chief Technology Officer, has notified the company of his intention to retire from his position effective July 31, 2026. His notice was provided on May 6, 2026.
The report also includes standard Inline XBRL cover page data exhibits, reflecting routine compliance with electronic reporting requirements.
Camden National Corporation reported sharply higher quarterly results for the three months ended March 31, 2026. Net income rose to $21.9 million from $7.3 million a year earlier, and diluted EPS increased to $1.29 from $0.43.
Net interest income grew to $52.4 million, helped by lower interest expense, while the provision for credit losses dropped to $0.6 million from $9.4 million. Non-interest expense declined mainly because prior-year merger and acquisition costs of $7.5 million did not recur. Total loans were stable at about $5.0 billion, deposits increased to $5.59 billion, and total assets were $7.0 billion. Capital ratios at both the holding company and the bank remained well above regulatory minimums, with the bank’s common equity Tier 1 ratio at 12.60%.